Keyphrases
Pharmacy Faculty
100%
Community Hospital
75%
Pharmacy Students
75%
Faculty Satisfaction
66%
Anticoagulation
58%
Activated Partial Thromboplastin
50%
Heparin Monitoring
50%
Pharmacy Assessment
50%
Venous Thromboembolism Prophylaxis
50%
Corticotropin
50%
Item Quality
50%
Educational Value
50%
Geriatric Patients
50%
Student-generated Questions
50%
Participant Satisfaction
50%
Ischemic Stroke
50%
Wegener's Granulomatosis
50%
Ibutilide
50%
Non-surgical Patients
50%
Vitamin K
50%
Acutely Ill Patients
50%
Venous Thromboembolism Prevention
50%
Excessive Anticoagulation
50%
Omeprazole
50%
Long-term Retention
50%
Residency Education
50%
Graduate Pharmacy Education
50%
Inspra
50%
Spironolactone
50%
Eplerenone
50%
Professional Values
50%
Professional Socialization
50%
Vancomycin
50%
Drug Reaction
50%
Older Patients
50%
Clinical Efficacy
50%
Hypertension
50%
Biotechnology
50%
Pharmacotherapy
50%
Pharmacy
50%
Primary Care
50%
Fever
50%
CNS Involvement
50%
Adolescent Females
50%
Junior Faculty
50%
Neutropenia
50%
Pharmacy Residency
50%
Clinical Safety
50%
Funding Mechanisms
50%
Assessment Programs
50%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
100%
Disease
60%
Heparin
58%
Gout
50%
Ibutilide
50%
Immunoglobulin
50%
Corticotropin
50%
Thromboplastin
50%
Calcium Oxide
50%
Pharmaceutical Care
50%
Wegener Granulomatosis
50%
Cyanocobalamin Deficiency
50%
Vitamin B12
50%
Vitamin K Group
50%
Omeprazole
50%
Eplerenone
50%
Adverse Event
45%
Spironolactone
33%
Cyclophosphamide
27%
Replacement Therapy
20%
Cobalamin
20%
Aldosterone
16%
Anticoagulation Therapy
16%
Androgen Receptor
16%
Heart Left Ventricle Failure
16%
Progesterone Receptor
16%
Infarction
16%
Dyslipidemia
16%
Anticoagulant Agent
16%
Warfarin
16%
Hypotension
16%
Potassium Sparing Diuretic Agent
16%
Retrospective Study
15%
Colchicine
14%
Prednisone
11%
Tonic Clonic Seizure
11%
Physical Disease by Body Function
10%
Intranasal Route
10%
Malabsorption
10%
Clinical Trial
10%
Gastrointestinal Disease
10%
Route of Administration
8%
Randomized Controlled Trial
8%
Enoxaparin
8%
Fondaparinux
8%
Dalteparin
8%
Monotherapy
8%
Non-Steroidal Anti-Inflammatory Drug
7%
Heart Atrium Flutter
7%
Inflammation
7%
Medicine and Dentistry
Geriatrics
50%
Restylane
50%
Brain Ischemia
50%
Knee Osteoarthritis
50%
Vancomycin
50%
Drug Hypersensitivity
50%
Neutropenia
50%
Adolescence
50%
Apoplexy
50%
Granulomatosis with Polyangiitis
50%
Vitamin B12 Deficiency
50%
Cyanocobalamin
50%
Venous Thromboembolism
50%
Immunity
50%
Immunoglobulin
50%
Omeprazole
50%
Disease
44%
Drug Fever
33%
Cyclophosphamide
27%
Adverse Event
25%
Clinical Feature
16%
Osteomyelitis
16%
Contraindication
16%
Antithrombotic
16%
Substitution Therapy
16%
Cobalamin
16%
Prednisone
11%
Central Nervous System
11%
Epileptic Seizure
11%
Organ Systems
11%
Electroencephalogram
11%
Tonic-Clonic Seizure
11%
Magnetic Resonance Imaging
11%
Dietary Intake
8%
Physical Disease by Body Function
8%
Elderly Patient
8%
Joint Function
8%
Symptomatic Treatment
8%
Functional Status
8%
Protein Intake
8%
Gastrointestinal Disease
8%
Awareness
8%
Dalteparin Sodium
8%
Patient Care
8%
Kidney Function
8%
Monotherapy
8%
Heparin
8%
Fondaparinux
8%
Intranasal Route
8%
Malabsorption
8%